The Technical University of Munich’s Central Institute for Medical Technologies (IMETUM) and the ITM Group have initiated a collaborative scientific program “BetaTop” with the objective to study and explore the therapeutic effects and healing mechanism of Beta Radiation (i.e. Rhenium-188) in the treatment of Skin Cancer and Re-Stenosis Therapy in endovascular treatments.

The Program is intended to address the macroscopic, microscopic and cellular aspects of Beta-Emitter and Topical Therapies and will be performed in collaboration with a group of leading medical and scientific institutions involved in the development of Epidermal Radioisotope Therapy and Endovascular Therapy.

Dr. Tuomo Nikula, Director of Technology Development of the ITM Group, has been appointed as Program Manager for the "BetaTop" program.

For further information please contact: This e-mail address is being protected from spambots. You need JavaScript enabled to view it